Description

Benzyl (3S,4R)-3-Ethyl-4-(3-Tosyl-3H-Imidazo[1,2-A]Pyrrolo[2,3-E]Pyrazin-8-Yl)Pyrrolidine-1-Carboxylate is a sophisticated heterocyclic building block and advanced intermediate of significant interest in modern organic synthesis. Its complex fused-ring structure, featuring imidazo and pyrrolopyrazine motifs, makes it a valuable scaffold for constructing novel molecular architectures. This compound is primarily utilized by research and development teams in the pharmaceutical and biotechnology sectors, where it serves as a key precursor in the synthesis of targeted therapeutic agents, particularly in oncology and antiviral drug discovery programs.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel small-molecule drug candidates, especially kinase inhibitors and other targeted therapies.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis to explore new bioactive chemical space.
• Oncology Drug Discovery: Serves as a building block for compounds targeting specific pathways involved in cancer cell proliferation and survival.
• Biochemical Probe Development: Employed in the design and synthesis of chemical probes for studying enzyme function and cellular signaling pathways.
• Process Chemistry & Scale-Up: Used in the development and optimization of synthetic routes for active pharmaceutical ingredients (APIs) under Good Manufacturing Practice (GMP) guidelines.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical clients with custom synthesis and intermediate production.

Basic Information

Product Name	Benzyl (3S,4R)-3-Ethyl-4-(3-Tosyl-3H-Imidazo[1,2-A]Pyrrolo[2,3-E]Pyrazin-8-Yl)Pyrrolidine-1-Carboxylate
CAS No.	1708997-42-5
Molecular Formula	C31H31N5O4S
Molecular Weight	569.68 g/mol
Synonyms	1-Pyrrolidinecarboxylic acid, 3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-, benzyl ester, (3S,4R)-; (3S,4R)-Benzyl 3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate; Benzyl (3S,4R)-3-ethyl-4-[3-(4-methylphenyl)sulfonyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]pyrrolidine-1-carboxylate; 1708997-42-5; Advanced Pharmaceutical Intermediate; Tosyl-Imidazopyrrolopyrazine Derivative
EINECS	Contact for details

Quality Control

This high-value intermediate is produced under strict quality management systems. Every batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided, detailing results from HPLC, NMR, and mass spectrometry. Our quality commitment aligns with the standards expected for pharmaceutical development, supporting regulatory filings. Specifications can be tailored to meet specific project requirements for purity (typically >95% to >98% by HPLC) and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). For long-term storage, consider keeping the material under an inert atmosphere at lower temperatures (e.g., -20°C) to maximize stability. Keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	< 20 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.